Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mutat Res ; 483(1-2): 19-26, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11600128

ABSTRACT

Modifications in the control sequences of tumor suppressor genes have been found to play a role in the activation or inactivation of these genes and may play an important role in tumorigenesis. For example, hypermethylation of CpG islands and promoter polymorphisms have been found to be involved in transcriptional repression. A decrease in the levels of expression of one such tumor suppressor gene, the TGFbeta type II receptor (TbetaR-II), has been associated with increased tumorigenicity in a number of human tumors. Genetic alterations have been described in several tumor types in the coding region of this gene. However, no comprehensive search for genetic alterations in the TbetaR-II promoter has been reported. Genetic alterations in the promoter of the TbetaR-II gene could inhibit binding of putative regulatory factors. For example, we have reported a A-364-G alteration in the TbetaR-II promoter, which results in decreased transcriptional activity. In this study, we analyzed the 1.0kb region upstream of the TbetaR-II transcriptional start site and found genetic alterations in 46% of the head and neck squamous cell carcinoma (SqCC) samples examined. The most frequent alteration was a G-875-A alteration, present in 41.6% of the samples. Analysis of normal healthy individuals showed a similar frequency of this alteration, suggesting that alterations within the TbetaR-II promoter are unlikely to account for the decreased expression of TbetaR-II in head and neck SqCC.


Subject(s)
Mutation , Promoter Regions, Genetic , Receptors, Transforming Growth Factor beta/genetics , Base Sequence , Carcinoma, Squamous Cell/genetics , Cell Line , Cloning, Molecular , DNA Primers/genetics , Gene Expression , Genes, Tumor Suppressor , Head and Neck Neoplasms/genetics , Humans , Plasmids/genetics , Point Mutation , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Protein Serine-Threonine Kinases , Receptor, Transforming Growth Factor-beta Type II , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...